These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3861793)

  • 41. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigen.
    Dienhart DG; Schmelter RF; Lear JL; Miller GJ; Glenn SD; Bloedow DC; Kasliwal R; Moran P; Seligman P; Murphy JR
    Cancer Res; 1990 Nov; 50(21):7068-76. PubMed ID: 2170015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
    Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
    Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.
    Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA
    Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
    Reiners C; Eilles C; Spiegel W; Becker W; Börner W
    Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer.
    Cook CH; Hinkle GH; Thurston MO; Martin EW
    Cancer Biother Radiopharm; 1996 Dec; 11(6):415-22. PubMed ID: 10851502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.
    Hunter RE; Doherty P; Griffin TW; Gionet M; Hnatowich DJ; Bianco JA; Dillon MB
    Gynecol Oncol; 1987 Jul; 27(3):325-39. PubMed ID: 3497845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
    Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
    Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.
    Sakahara H; Endo K; Nakashima T; Koizumi M; Ohta H; Torizuka K; Furukawa T; Ohmomo Y; Yokoyama A; Okada K
    J Nucl Med; 1985 Jul; 26(7):750-5. PubMed ID: 2409251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
    Matthews DC; Badger CC; Fisher DR; Hui TE; Nourigat C; Appelbaum FR; Martin PJ; Bernstein ID
    Cancer Res; 1992 Mar; 52(5):1228-34. PubMed ID: 1531324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibodies.
    Taylor A; Milton W; Eyre H; Wu FP; Christian P; Alazraki N; Datz F; Unger MW
    NCI Monogr; 1987; (3):25-31. PubMed ID: 3821915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients.
    Buist MR; Kenemans P; den Hollander W; Vermorken JB; Molthoff CJ; Burger CW; Helmerhorst TJ; Baak JP; Roos JC
    Cancer Res; 1993 Nov; 53(22):5413-8. PubMed ID: 8221680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study.
    Kramer EL; DeNardo SJ; Liebes L; Kroger LA; Noz ME; Mizrachi H; Salako QA; Furmanski P; Glenn SD; DeNardo GL
    J Nucl Med; 1993 Jul; 34(7):1067-74. PubMed ID: 8315480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative studies using 125I- and 111In-labeled monoclonal antibodies.
    Otsuka FL; Fleischman JB; Welch MJ
    Int J Rad Appl Instrum B; 1986; 13(4):325-34. PubMed ID: 3793486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.